{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:34:03Z","timestamp":1769272443616,"version":"3.49.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"9-10","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Changes to severe acute respiratory syndrome 2 (SARS-CoV-2) vaccine guidance since their initial authorization may lead to confusion and hesitancy. Suggested recommendations for an annual SARS-CoV-2 vaccine naturally draw comparisons with the influenza vaccine program. Considering viral and vaccine characteristics between these pathogens provides an important perspective that can help increase vaccine confidence with SARS-CoV-2 vaccines.<\/jats:p>","DOI":"10.1093\/milmed\/usac243","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:06:25Z","timestamp":1660046785000},"page":"223-224","source":"Crossref","is-referenced-by-count":2,"title":["Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Boosters: An Influenza Vaccine Perspective"],"prefix":"10.1093","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-1429","authenticated-orcid":false,"given":"David R","family":"Sayers","sequence":"first","affiliation":[{"name":"Department of the Air Force, AFMRA\/SG3PM , Falls Church, VA 22042, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"issue":"19","key":"2023083018184603500_R1","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1001\/jama.2022.7469","article-title":"COVID-19 vaccination\u2014becoming part of the new normal","volume":"327","author":"Marks","year":"2022","journal-title":"JAMA"},{"issue":"17","key":"2023083018184603500_R2","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1056\/NEJMe2203329","article-title":"Covid-19 boosters\u2014where from here?","volume":"386","author":"Offit","year":"2022","journal-title":"New Engl J Med"},{"key":"2023083018184603500_R3","article-title":"How flu vaccine effectiveness and efficacy ate measured","author":"Centers for Disease Control and Prevention"},{"issue":"1","key":"2023083018184603500_R4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/epirev\/mxj003","article-title":"Immunization to protect the US Armed Forces: heritage, current practice, and prospects","volume":"28","author":"Grabenstein","year":"2006","journal-title":"Epidemiol Rev"},{"issue":"9","key":"2023083018184603500_R5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMp1400034","article-title":"Preventing and controlling influenza with available interventions","volume":"370","author":"Uyeki","year":"2014","journal-title":"New Engl J Med"},{"issue":"5152","key":"2023083018184603500_R6","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.15585\/mmwr.mm705152e3","article-title":"Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant cluster \u2014 Nebraska, November\u2013December 2021","volume":"70","author":"Jansen","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023083018184603500_R7","article-title":"Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)","author":"Center for Disease Control (CDC)","year":"2020"},{"issue":"4","key":"2023083018184603500_R8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofx212","article-title":"Comparison of the outcomes of individuals with medically attended influenza A and B virus infections enrolled in 2 international cohort studies over a 6-year period: 2009\u20132015","volume":"4","author":"Dwyer","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"2023083018184603500_R9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.mayocp.2020.04.010","article-title":"The early natural history of SARS-CoV-2 infection: clinical observations from an urban, ambulatory COVID-19 clinic","volume":"95","author":"Cohen","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"2023083018184603500_R10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.immuni.2022.05.004","article-title":"Instructing durable humoral immunity for COVID-19 and other vaccinable diseases","volume":"55","author":"Bhattacharya","year":"2022","journal-title":"Immunity"},{"issue":"14","key":"2023083018184603500_R11","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1101\/2022.03.18.484953","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"issue":"6513","key":"2023083018184603500_R12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aaz8432","article-title":"Influenza vaccine\u2013induced human bone marrow plasma cells decline within a year after vaccination","volume":"370","author":"Davis","year":"2020","journal-title":"Science"},{"key":"2023083018184603500_R13","article-title":"Vaccines licensed for use in the United States","author":"U.S. Food and Drug Administration"},{"issue":"12","key":"2023083018184603500_R14","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/188\/9-10\/223\/51307905\/usac243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/188\/9-10\/223\/51307905\/usac243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T18:18:53Z","timestamp":1693419533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/188\/9-10\/223\/6658843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":14,"journal-issue":{"issue":"9-10","published-online":{"date-parts":[[2022,8,9]]},"published-print":{"date-parts":[[2023,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usac243","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2022,8,9]]}}}